Chinese Journal of Stroke ›› 2015, Vol. 10 ›› Issue (08): 689-694.
Previous Articles Next Articles
Received:
2015-02-26
Online:
2015-08-20
Published:
2015-08-20
马虹印 1,邢英琦 2,杨弋
通讯作者:
杨弋
doctoryangyi@163.com
MA Hong-Yin, XING Ying-Qi,YANG Yi. Advance in Cerebral Autoregulation of Hemorrhagic Stroke[J]. Chinese Journal of Stroke, 2015, 10(08): 689-694.
马虹印 1,邢英琦 2,杨弋. 出血性卒中的脑血流自动调节研究进展[J]. 中国卒中杂志, 2015, 10(08): 689-694.
1 Lassen NA. Cerebral blood flow and oxygenconsumption in man[J]. Physiol Rev, 1959, 39:183-238.2 Panerai RB. Assessment of cerebral pressureautoregulation in humans--a review of measurementmethods[J]. Physiol Meas, 1998, 19:305-338.3 Aaslid R, Lindegaard KF, Sorteberg W, et al. Cerebralautoregulation dynamics in humans[J]. Stroke, 1989,20:45-52.4 Panerai RB, Rennie JM, Kelsall AW, et al. Frequency-domain analysis of cerebral autoregulation fromspontaneous fluctuations in arterial blood pressure[J].Med Biol Eng Comput, 1998, 36:315-322.5 Diehl RR. Cerebral autoregulation studies in clinicalpractice[J]. Eur J Ultrasound, 2002, 16:31-36.6 Sudlow CL, Warlow CP. Comparable studies of theincidence of stroke and its pathological types:Resultsfrom an international collaboration. InternationalStroke Incidence Collaboration[J]. Stroke, 1997,28:491-499.7 Immink RV, van den Born BJ, van Montfrans GA,et al. Impaired cerebral autoregulation in patientswith malignant hypertension[J]. Circulation, 2004,110:2241-2245.8 Anderson CS, Huang Y, Wang JG, et al. Intensiveblood pressure reduction in acute cerebralhaemorrhage trial (INTERACT):A randomised pilottrial[J]. Lancet Neurol, 2008, 7:391-399.9 Delcourt C, Huang Y, Wang J, et al. The second (main)phase of an open, randomised, multicentre study toinvestigate the effectiveness of an intensive bloodpressure reduction in acute cerebral haemorrhage trial(INTERACT2)[J]. Int J Stroke, 2010, 5:110-116.10 Sato S, Yamamoto H, Qureshi AI, et al. AntihypertensiveTreatment of Acute Cerebral Hemorrhage (ATACH)-II at Japan site:Study design and advance constructionof domestic research network[J]. Rinsho Shinkeigaku,2012, 52:642-650.11 Kuwata N, Kuroda K, Funayama M, et al.Dysautoregulation in patients with hypertensiveintracerebral hemorrhage. A SPECT study[J].Neurosurg Rev, 1995, 18:237-245.12 Powers WJ, Zazulia AR, Videen TO, et al.Autoregulation of cerebral blood flow surroundingacute (6 to 22 hours) intracerebral hemorrhage[J].Neurology, 2001, 57:18-24.13 Gould B, McCourt R, Asdaghi N, et al. Autoregulationof cerebral blood flow is preserved in primaryintracerebral hemorrhage[J]. Stroke, 2013, 44:1726-1728.14 Reinhard M, Neunhoeffer F, Gerds TA, et al.Secondary decline of cerebral autoregulation isassociated with worse outcome after intracerebralhemorrhage[J]. Intensive Care Med, 2010, 36:264-271.15 Nakagawa K, Serrador JM, LaRose SL, et al.Dynamic cerebral autoregulation after intracerebralhemorrhage:A case-control study[J]. BMC Neurol,2011, 11:108.16 Oeinck M, Neunhoeffer F, Buttler KJ, et al. Dynamiccerebral autoregulation in acute intracerebralhemorrhage[J]. Stroke, 2013, 44:2722-2728.17 Velthuis BK, van Leeuwen MS, Witkamp TD, et al.CT angiography:Source images and postprocessingtechniques in the detection of cerebral aneurysms[J].AJR Am J Roentgenol, 1997, 169:1411-1417.18 Robertson EG. Cerebral lesions due to intracranialaneurysms[J]. Brain, 1949, 72:150-185.19 Macdonald RL, Kassell NF, Mayer S, et al.Clazosentan to overcome neurological ischemia andinfarction occurring after subarachnoid hemorrhage(CONSCIOUS-1):Randomized, double-blind, placebo-controlled phase 2 dose-finding trial[J]. Stroke, 2008,39:3015-3021.20 Budohoski KP, Guilfoyle M, Helmy A, et al. Thepathophysiology and treatment of delayed cerebralischaemia following subarachnoid haemorrhage[J]. JNeurol Neurosurg Psychiatry, 2014, 85:1343-1353.21 Budohoski KP, Czosnyka M, Kirkpatrick PJ, et al.Clinical relevance of cerebral autoregulation followingsubarachnoid haemorrhage[J]. Nat Rev Neurol, 2013,9:152-163.22 Soehle M, Czosnyka M, Pickard JD, et al. Continuousassessment of cerebral autoregulation in subarachnoidhemorrhage[J]. Anesth Analg, 2004, 98:1133-1139.23 Budohoski KP, Czosnyka M, Kirkpatrick PJ, etal. Bilateral failure of cerebral autoregulation isrelated to unfavorable outcome after subarachnoidhemorrhage[J]. Neurocrit Care, 2015, 22:65-73.24 Schmieder K, Moller F, Engelhardt M, et al. Dynamiccerebral autoregulation in patients with rupturedand unruptured aneurysms after induction of generalanesthesia[J]. Zentralbl Neurochir, 2006, 67:81-87.25 Otite F, Mink S, Tan CO, et al. Impaired cerebralautoregulation is associated with vasospasmand delayed cerebral ischemia in subarachnoidhemorrhage[J]. Stroke, 2014, 45:677-682.26 Jaeger M, Schuhmann MU, Soehle M, et al. Continuousmonitoring of cerebrovascular autoregulation aftersubarachnoid hemorrhage by brain tissue oxygenpressure reactivity and its relation to delayed cerebralinfarction[J]. Stroke, 2007, 38:981-986.27 Jaeger M, Soehle M, Schuhmann MU, et al.Clinical significance of impaired cerebrovascularautoregulation after severe aneurysmal subarachnoidhemorrhage[J]. Stroke, 2012, 43:2097-2101.28 Steiner LA, Pfister D, Strebel SP, et al. Near-infrared spectroscopy can monitor dynamic cerebralautoregulation in adults[J]. Neurocrit Care, 2009,10:122-128.29 Zweifel C, Castellani G, Czosnyka M, et al. Continuousassessment of cerebral autoregulation with near-infrared spectroscopy in adults after subarachnoidhemorrhage[J]. Stroke, 2010, 41:1963-1968.30 Budohoski KP, Czosnyka M, Smielewski P, etal. Cerebral autoregulation after subarachnoidhemorrhage:Comparison of three methods[J]. J CerebBlood Flow Metab, 2013, 33:449-456.31 Tseng MY, Czosnyka M, Richards H, et al. Effects ofacute treatment with statins on cerebral autoregulationin patients after aneurysmal subarachnoidhemorrhage[J]. Neurosurg Focus, 2006, 21:E10.32 Tseng MY, Czosnyka M, Richards H, et al. Effectsof acute treatment with pravastatin on cerebralvasospasm, autoregulation, and delayed ischemicdeficits after aneurysmal subarachnoid hemorrhage:Aphase II randomized placebo-controlled trial[J].Stroke, 2005, 36:1627-1632.33 Tseng MY, Hutchinson PJ, Czosnyka M, et al. Effectsof acute pravastatin treatment on intensity of rescuetherapy, length of inpatient stay, and 6-monthoutcome in patients after aneurysmal subarachnoidhemorrhage[J]. Stroke, 2007, 38:1545-1550.34 Tseng MY, Hutchinson PJ, Richards HK, et al. Acutesystemic erythropoietin therapy to reduce delayedischemic deficits following aneurysmal subarachnoidhemorrhage:A phase II randomized, double-blind,placebo-controlled trial[J]. J Neurosurg, 2009,111:171-180.35 Steiner LA, Czosnyka M, Piechnik SK, et al.Continuous monitoring of cerebrovascular pressurereactivity allows determination of optimal cerebralperfusion pressure in patients with traumatic braininjury[J]. Crit Care Med, 2002, 30:733-738.36 Aries MJ, Czosnyka M, Budohoski KP, et al.Continuous determination of optimal cerebralperfusion pressure in traumatic brain injury[J]. CritCare Med, 2012, 40:2456-2463.37 Morgenstern LB, Hemphill JC 3rd, Anderson C, etal. Guidelines for the management of spontaneousintracerebral hemorrhage:A guideline for healthcareprofessionals from the American Heart Association/American Stroke Association[J]. Stroke, 2010,41:2108-2129.38 Diedler J, Sykora M, Rupp A, et al. Impaired cerebralvasomotor activity in spontaneous intracerebralhemorrhage[J]. Stroke, 2009, 40:815-819.39 Diedler J, Santos E, Poli S, et al. Optimal cerebralperfusion pressure in patients with intracerebralhemorrhage:An observational case series[J]. Crit Care,2014, 18:R51.40 Bijlenga P, Czosnyka M, Budohoski KP, et al."Optimal cerebral perfusion pressure" in poor gradepatients after subarachnoid hemorrhage[J]. NeurocritCare, 2010, 13:17-23. |
[1] | WANG Jingyi, LI Hua, CAO Liming. Application Progress of the Recumbent-Upright Test Using Transcranial Doppler in Cerebrovascular Diseases [J]. Chinese Journal of Stroke, 2024, 19(9): 998-1003. |
[2] |
LI Yangyang, FANG Jian, WANG Xiaoxue.
Effects of Honokiol on Neurological Injury and Cognitive Function in Mice with Intracerebral Hemorrhage by Regulating BDNF-TrkB-CREB Signaling Pathway [J]. Chinese Journal of Stroke, 2024, 19(9): 1048-1057. |
[3] | ZHAO Yan, YAO Jingxin, PENG Yuming. A Report of Simultaneous Complications of Ischemic Stroke and Intracerebral Hemorrhage in Geriatric Patients Undergoing Craniotomy for Tumor Resections during the Perioperative Period [J]. Chinese Journal of Stroke, 2024, 19(7): 797-802. |
[4] | ZHAO Xin, XUE Wei, ZHU Xinli, JING Dongqing, HONG Fan, GUO Xiao, LIU Junling. Paroxysmal Nocturnal Hemoglobinuria with Posterior Reversible Encephalopathy Syndrome: A Case Report [J]. Chinese Journal of Stroke, 2024, 19(6): 699-705. |
[5] | LI Zhiming, WANG Zijie, LI Qi. Interpretation of the American Stroke Association Code ICH Expert Consensus Statement [J]. Chinese Journal of Stroke, 2024, 19(6): 714-724. |
[6] | LI Chenhong, JIANG Chenli, WANG Jinhui, HUANG Sheng. Analysis of Influencing Factors and Construction of Prediction Models for Pulmonary Infection after Minimally Invasive Intracranial Hematoma Removal in Patients with Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(5): 532-538. |
[7] | DING Zeyu, JI Zeqiang, WU Jianwei, KANG Kaijiang, ZHAO Xingquan. Risk Factors of Early Neurological Deterioration of Patients after Minimally Invasive Surgery in Supratentorial Hypertensive Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(5): 545-551. |
[8] | ZHANG Qing, WANG Xu, ZHANG Qing. A Case Report of “Heart” Shaped Primary Medullary Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(2): 197-201. |
[9] | LI Dayu, GUO Shaolei, ZHANG Bo, HUANG Zhipeng, YE Weiwei, YAO Liang. Effects of Penehyclidine Hydrochloride on the Blood-Brain Barrier and ROCK2, CLDN5, and AQP-4 Expression of Brain Tissue in Rats with Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(10): 1180-1187. |
[10] | JU Jiajun, WANG Xinxin, HANG Lihua. Research Progress on the Correlation between Neuroinflammation and Brain Iron Metabolism after Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(10): 1205-1214. |
[11] | The Cerebrovascular Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases. Medical Quality Control Indicators for Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(1): 44-49. |
[12] | WANG Jing, LI Zixiao, DONG Qiang, ZHAO Xingquan. Interpretation of Medical Quality Control Indicators for Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(1): 50-54. |
[13] | YANG Jiaxin, HE Chunyu, LIU Lei, CHEN Wenbo, XIE Yan. Prediction Models of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review [J]. Chinese Journal of Stroke, 2024, 19(1): 76-86. |
[14] | WANG Chao, HU Yongzhen, LI Xuesong. Predictive Research Progress on Shunt-Dependent Hydrocephalus after Aneurysmal Subarachnoid Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(1): 87-93. |
[15] | ZHANG Qian, JI Ruijun, ZHAO Meng, WANG Wenjuan, LU Jingjing, LI Na, LIU Yanfang, BIAN Liheng, YU Songlin, LI Hao, ZHANG Qian, WU Jianwei, WANG Dandan, WANG Jing, LI Zhaoxia, JIANG Ruixuan, KANG Kaijiang, XUE Yimeng, YA Xiaolong, HE Qiheng, MO Shaohua, ZHAO Xingquan, ZHAO Jizong, the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases ( Contributed equally). Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt) ——Chapter Five Clinical Management of Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2023, 18(9): 1014-1023. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||